KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 105 filers reported holding KEROS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14,304,588 | +614.9% | 448,701 | +801.0% | 0.00% | – |
Q2 2023 | $2,000,884 | -66.8% | 49,798 | -64.7% | 0.00% | -100.0% |
Q1 2023 | $6,019,420 | -12.3% | 140,970 | -1.4% | 0.00% | 0.0% |
Q4 2022 | $6,864,987 | +196.7% | 142,961 | +132.4% | 0.00% | – |
Q3 2022 | $2,314,000 | -30.1% | 61,521 | -48.6% | 0.00% | – |
Q2 2022 | $3,310,000 | +17.4% | 119,798 | +131.1% | 0.00% | – |
Q1 2022 | $2,819,000 | +576.0% | 51,828 | +625.8% | 0.00% | – |
Q4 2021 | $417,000 | -86.9% | 7,141 | -91.1% | 0.00% | – |
Q3 2021 | $3,173,000 | +225.1% | 80,212 | +249.1% | 0.00% | – |
Q2 2021 | $976,000 | +5322.2% | 22,980 | +7907.0% | 0.00% | – |
Q1 2021 | $18,000 | -99.7% | 287 | -99.6% | 0.00% | -100.0% |
Q4 2020 | $5,336,000 | +22133.3% | 75,635 | +11963.0% | 0.00% | – |
Q3 2020 | $24,000 | -70.4% | 627 | -70.9% | 0.00% | – |
Q2 2020 | $81,000 | – | 2,153 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 396,911 | $21,584,000 | 5.10% |
Deep Track Capital, LP | 1,380,306 | $75,061,000 | 4.81% |
Opaleye Management Inc. | 265,750 | $14,451,000 | 4.49% |
Octagon Capital Advisors LP | 340,214 | $18,501,000 | 4.00% |
First Light Asset Management, LLC | 658,145 | $35,790,000 | 3.16% |
Altium Capital Management LP | 126,000 | $6,852,000 | 2.29% |
Nantahala Capital Management | 816,830 | $44,419,000 | 1.96% |
Orbimed Advisors | 1,679,417 | $91,327,000 | 1.48% |
CHI Advisors LLC | 62,229 | $3,384,000 | 1.44% |
Parkman Healthcare Partners LLC | 72,690 | $3,953,000 | 1.16% |